Search results for "Hamd"

showing 10 items of 14 documents

Results of an Open Clinical Trial of Brofaromine (CGP 11 305 A), a Competitive, Selective, and Short-Acting Inhibitor of MAO-A in Major Endogenous De…

1987

In an open clinical trial the authors treated 18 hospitalized patients suffering from endogenous depression with brofaromine (CGP 11305A), a competitive, selective, and short-acting inhibitor of type A monoamine oxidase (MAO). Four patients were defined as good responders, as they had a final HAMD score of between 0 and 7 points. Four patients were judged as improved, with final HAMD scores of between 8 and 15 points, while the remaining eight patients failed to respond (final HAMD score greater than or equal to 16 points). The major observations were a beneficial influence on drive in most patients, while paranoid symptoms worsened markedly, rendering the substance contraindicated in psych…

AdultBlood PlateletsMaleSerotoninMonoamine Oxidase Inhibitorsmedicine.medical_treatmentSleep REMTyraminePsychotic depressionPharmacologyPersonality AssessmentDexamethasonechemistry.chemical_compoundPiperidinesBrofaromineHamdmedicineHumansPharmacology (medical)Monoamine OxidaseDepression (differential diagnoses)AgedDepressive DisorderChemotherapybiologyElectroencephalographyGeneral MedicineMiddle Agedmedicine.diseaseClinical trialPsychiatry and Mental healthchemistryEndogenous depressionbiology.proteinFemaleMonoamine oxidase APsychologyPharmacopsychiatry
researchProduct

Standardized rater training for the Hamilton Depression Rating Scale (HAMD-17) in psychiatric novices.

2003

Abstract Background: Despite the long and widespread use of the Hamilton Depression Rating Scale (HAMD), standardized reliability studies in inexperienced raters are not available. Methods: Rater training was carried using three videotaped interviews with depressed patients in 21 psychiatric novices who had negligible previous experience with the HAMD. Chance-corrected coefficients of rating agreement with expert standards (weighted κ , ICC) were computed for single items and the total score of the HAMD. Results: The results demonstrate sufficiently high interrater reliability ( κ >0.60) for most of the HAMD items and the total score (ICC=0.57–0.73). Three standardized HAMD training session…

AdultMaleObserver VariationPsychiatric Status Rating ScalesPsychiatrymedicine.medical_specialtyPsychometricsItem analysisDepressionTeachingRater trainingPsychiatry and Mental healthClinical PsychologyInter-rater reliabilityRating scaleSurveys and QuestionnairesHamdmedicineHumansGeneralizability theoryFemalePsychologyPsychiatryDepression (differential diagnoses)Journal of affective disorders
researchProduct

Insight in schizophrenia–course and predictors during the acute treatment phase of patients suffering from a schizophrenia spectrum disorder

2012

AbstractBackgroundTo analyse insight of illness during the course of inpatient treatment, and to identify influencing factors and predictors of insight.MethodsInsight into illness was examined in 399 patients using the item G12 of the Positive and Negative Syndrome Scale (“lack of insight and judgement”). Ratings of the PANSS, HAMD, UKU, GAF, SOFAS, SWN-K and Kemp's compliance scale were performed and examined regarding their potential association with insight. The item G12 was kept as an ordinal variable to compare insight between subgroups of patients.ResultsAlmost 70% of patients had deficits in their insight into illness at admission. A significant improvement of impairments of insight …

AdultMaleOrdinal datamedicine.medical_specialtyMedizin03 medical and health sciences0302 clinical medicineTreatment targetsPredictive Value of TestsHamdmedicineHumansPsychiatryPsychiatric Status Rating ScalesPositive and Negative Syndrome ScaleAwarenessmedicine.disease030227 psychiatryPsychiatry and Mental healthInsight into illnessSchizophreniaAcute DiseaseSchizophreniaFemaleSchizophrenic PsychologyPsychology030217 neurology & neurosurgeryClinical psychologySchizophrenia spectrumEuropean Psychiatry
researchProduct

Comparative analysis of observer depression scales

1985

Abstract The Hamilton Depression Scale (HAMD), Bech Rafaelsen Melancholia Scale (BRMS) and Montgomery Asberg Depression Rating Scale (MADRS) are analyzed according to mean discriminatory power, internal consistency, homogeneity and transferability. The analysis was done separately in different samples of patients with depressive syndromes: a) operationally defined depressive syndrome; b) Major Depressive Disorder (RDC); c) Major Depressive Disorder, endogenous type (RDC). BRMS and MADRS were superior to HAMD in all evaluated aspects. Further, the BRMS was superior to MADRS according to the criteria of homogeneity and transferability.

AdultMalePsychiatric Status Rating ScalesDepressive Disordermedicine.medical_specialtyHamilton depression scalePsychometricsStatistics as TopicTest validityMiddle Agedmedicine.diseaseDiscriminatory powerPsychiatry and Mental healthMontgomery–Åsberg Depression Rating ScaleMelancholiaHamdmedicineHumansMajor depressive disorderFemalemedicine.symptomPsychiatryPsychologyActa Psychiatrica Scandinavica
researchProduct

Differential effects of the enantiomers R(-) and S(+) oxaprotiline on major endogenous depression, the sleep EEG and neuroendocrine secretion: studie…

1993

The effects of the optically active enantiomers of oxaprotiline (OXP), R(-) OXP and S(+) OXP, on depressive symptomatology and the sleep EEG were investigated in two separate exploratory studies. In addition, the neuroendocrine profile of both compounds was characterized in normal controls. In the patients treated with a daily oral dose of 150 mg S(+) OXP we found a Hamilton depression score that decreased from 29.1 +/- 1.8 (SEM) on day 0 to 14.7 +/- 3.2 on day 28 (P0.01). Six patients were judged to be full responders (HAMD score 0-7 points), three were improved (HAMD score 8-15) and four were nonresponders (HAMD score16). The therapeutic effect achieved with 150 mg R(-) OXP daily was less…

AdultMalemedicine.medical_specialtyHydrocortisoneSleep REMchemistry.chemical_compoundNorepinephrineInternal medicineHamdmedicineHumansPharmacology (medical)SecretionTestosteroneBiological PsychiatryTestosteroneAgedPharmacologyPsychiatric Status Rating ScalesDepressive DisorderNeurosecretionPenile ErectionTherapeutic effectOxaprotilineElectroencephalographyStereoisomerismMiddle AgedProlactinAntidepressive AgentsProlactinPsychiatry and Mental healthEndocrinologyNeurologychemistryMaprotilineGrowth HormoneEndogenous depressionFemaleNeurology (clinical)EnantiomerPsychologySleepEuropean neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology
researchProduct

Outcome of suicidal patients with schizophrenia: results from a naturalistic study.

2010

Schennach-Wolff R, Jager M, Seemuller F, Obermeier M, Schmauss M, Laux G, Pfeiffer H, Naber D, Schmidt LG, Gaebel W, Klosterkotter J, Heuser I, Maier W, Lemke MR, Ruther E, Klingberg S, Gastpar M, Moller H-J, Riedel M. Outcome of suicidal patients with schizophrenia: results from a naturalistic study. Objective:  Purpose was to assess suicidality before and at the time of admission in patients with schizophrenia and compare outcome differences. Method:  Biweekly PANSS (Positive and Negative Syndrome Scale), HAMD (Hamilton Depression Rating Scale) and UKU (Udvalg for Klinske Undersogelser Side Effect Rating Scale) ratings were evaluated in 339 in-patients with schizophrenic spectrum disorder…

AdultMalemedicine.medical_specialtyPsychosisMedizinPoison controlSuicide AttemptedComorbidityAkathisiaCohort StudiesHospitals University03 medical and health sciencesYoung Adult0302 clinical medicineRating scaleRisk FactorsGermanyHamdmedicineHumansPsychiatryPsychiatric Status Rating ScalesDepressive Disorder MajorPositive and Negative Syndrome ScaleIncidenceMiddle Agedmedicine.diseaseComorbidityHealth Surveys3. Good health030227 psychiatryPsychiatry and Mental healthCross-Sectional StudiesTreatment OutcomeSchizophreniaAcute DiseaseSchizophreniaFemaleSchizophrenic Psychologymedicine.symptomPsychology030217 neurology & neurosurgeryAkathisia Drug-InducedAntipsychotic AgentsActa psychiatrica Scandinavica
researchProduct

hs-CRP Predicts Improvement in Depression in Patients With Type 1 Diabetes and Major Depression Undergoing Depression Treatment: Results From the Dia…

2016

hs-CRP is elevated in depression (1), but evidence on decreases of hs-CRP during depression treatment or the role of hs-CRP in the prediction of response to depression treatment is still controversial (2,3). To date, no study has examined this association in patients with diabetes. As elevated hs-CRP increases the risk of diabetes complications in diabetes (4), we aimed to explore hs-CRP in patients with diabetes and major depression undergoing depression treatment based on the data of the Diabetes and Depression (DAD) study (5). Participants were randomized to 12 weeks (short-term phase) of diabetes-specific group cognitive behavioral therapy or sertraline treatment and followed up for 15 …

Advanced and Specialized NursingSertralineType 1 diabetesmedicine.medical_specialtybusiness.industryEndocrinology Diabetes and Metabolismmedicine.medical_treatmentType 2 diabetesmedicine.disease030227 psychiatryCognitive behavioral therapy03 medical and health sciences0302 clinical medicineInterquartile rangeDiabetes mellitusInternal medicineHamdInternal MedicineMedicinebusinessPsychiatry030217 neurology & neurosurgeryDepression (differential diagnoses)medicine.drugDiabetes Care
researchProduct

Effect of Vestibular Rehabilitation on Spontaneous Brain Activity in Patients With Vestibular Migraine: A Resting-State Functional Magnetic Resonance…

2019

Previous studies have shown that vestibular migraine (VM) is a cerebral disease with recurrent vertigo. Vestibular rehabilitation (VR) is an effective type of physical therapy for minimizing vestibular symptoms, as it improves vestibular compensation in patients with VM. Currently, the cerebral regions that are associated with the pathogenesis of VM are largely unknown. To further understand the underlying mechanisms of VM, we performed resting-state functional magnetic resonance imaging (fMRI) before and after 1 month of VR in 14 patients with VM. The Dizziness Handicap Inventory (DHI), the 36-Item Short-Form Health Survey (SF-36), the Hamilton Depression Scale (HAMD) and the Hamilton Anxi…

Cerebellummedicine.medical_specialtyBrain activity and meditationvestibular migraine050105 experimental psychologylcsh:RC321-571Vestibular migraine03 medical and health sciencesBehavioral Neuroscience0302 clinical medicinePhysical medicine and rehabilitationVertigovestibular rehabilitationHamdmedicine0501 psychology and cognitive scienceslcsh:Neurosciences. Biological psychiatry. Neuropsychiatryresting stateBiological PsychiatryOriginal ResearchVestibular systemmedicine.diagnostic_testbiologyResting state fMRIbusiness.industry05 social sciencesamplitude of low-frequency fluctuationHuman Neurosciencebiology.organism_classificationfunctional magnetic resonance imagingPsychiatry and Mental healthNeuropsychology and Physiological Psychologymedicine.anatomical_structureNeurologyFunctional magnetic resonance imagingbusiness030217 neurology & neurosurgeryFrontiers in Human Neuroscience
researchProduct

Therapeutic drug monitoring of tricyclic antidepressants: how does it work under clinical conditions?

2003

Therapeutic drug monitoring (TDM) of tricyclic antidepressants (TCA) is established in the treatment of depression to optimize outcome and safety. However, there are few reports on TDM under naturalistic clinical conditions. In the present study, we investigated a TDM group (TDM) and a randomly assigned parallel group without TDM (no-TDM) while on TCA treatment. Serum levels were analyzed in both cohorts, but feedback and dose recommendation were only provided for the TDM group. Serum levels of TCA were assessed by high-performance liquid chromatography (HPLC). The outcome was measured weekly using the Hamilton Depression Rating Scale (HAMD), the Clinical Global Impressions Scale (CGI), and…

Malemedicine.medical_specialtyAmitriptylinePharmacologyAntidepressive Agents Tricycliclaw.inventionTherapeutic indexRandomized controlled triallawInternal medicineHamdMedicineHumansPharmacology (medical)Amitriptylinechemistry.chemical_classificationPsychiatric Status Rating ScalesDepressive Disordermedicine.diagnostic_testbusiness.industryGeneral MedicineMiddle AgedDoxepinClinical trialPsychiatry and Mental healthTreatment OutcomechemistryTherapeutic drug monitoringFemaleDoxepinDrug Monitoringbusinessmedicine.drugTricyclicPharmacopsychiatry
researchProduct

Early reactions of brain-derived neurotrophic factor in plasma (pBDNF) and outcome to acute antidepressant treatment in patients with Major Depressio…

2011

Abstract In Major Depressive Disorder, a growing data base suggests that the onset of antidepressants’ action can be detected by improvement of depressive symptoms in the first 10–14 days of treatment. Previous studies showed that the mean concentration of the brain-derived neurotrophic factor (BDNF) in blood increases during antidepressant treatment and positively correlates with amelioration of MDD symptoms. We previously showed an association between very early changes of the serum BDNF concentration and treatment outcome ( Tadic et al., 2011 . Prog Neuropsychopharmacol Biol Psychiatry 35, 415–420). However, no study has yet investigated whether BDNF concentration in plasma increases in …

OncologyAdultMalemedicine.medical_specialtyTime FactorsEnzyme-Linked Immunosorbent AssayCellular and Molecular NeuroscienceYoung AdultNeurotrophic factorsInternal medicineHamdmedicineHumansPsychiatryDepression (differential diagnoses)PharmacologyBrain-derived neurotrophic factorPsychiatric Status Rating ScalesDepressive Disorder MajorInpatientsBrain-Derived Neurotrophic FactorMiddle Agedmedicine.diseaseAntidepressive AgentsROC CurveLinear ModelsAntidepressantBiomarker (medicine)Major depressive disorderAnxietyFemalemedicine.symptomPsychologyNeuropharmacology
researchProduct